comparemela.com

Latest Breaking News On - News ratings for amneal pharmaceuticals daily - Page 1 : comparemela.com

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $8.25 Consensus Target Price from Analysts

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average rating of “Buy” by the four ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on […]

Piper-sandler
News-ratings-for-amneal-pharmaceuticals-daily
Nasdaq
Amneal-pharmaceuticals-company-profile
Goldman-sachs-group
Amneal-pharmaceuticals
Amneal-pharmaceuticals-inc
Amneal-pharmaceuticals-stock-down
Sherbrooke-park-advisers
Atlanta-consulting-group-advisors
Hedge-funds-weigh-in-on-amneal-pharmaceuticals
Get-free-report

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 6.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s stock price shot up 6.4% on Tuesday . The company traded as high as $6.90 and last traded at $6.86. 685,390 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 1,502,379 shares. The stock had previously closed at $6.45. Analysts […]

Piper-sandler
Sherbrooke-park-advisers
Barclays
News-ratings-for-amneal-pharmaceuticals-daily
Amneal-pharmaceuticals
Atlanta-consulting-group-advisors
Nasdaq
Amneal-pharmaceuticals-company-profile
Amneal-pharmaceuticals-inc
Amneal-pharmaceuticals-stock-performance
Goldman-sachs-group
Institutional-investors-weigh-in-on-amneal-pharmaceuticals

The Goldman Sachs Group Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $8.00

The Goldman Sachs Group Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $8.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Ohio
United-states
Piper-sandler
News-ratings-for-amneal-pharmaceuticals-daily
Connor-clark-lunn-investment-management-ltd
Hedge-funds-weigh-in-on-amneal-pharmaceuticals
Barclays
Amneal-pharmaceuticals-inc
Goldman-sachs-group
Amneal-pharmaceuticals-stock-performance
Amneal-pharmaceuticals
Caxton-associates

Amneal Pharmaceuticals' (AMRX) "Buy" Rating Reiterated at Truist Financial

Amneal Pharmaceuticals' (AMRX) "Buy" Rating Reiterated at Truist Financial
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Goldman-sachs-group
Institutional-investors-weigh-in-on-amneal-pharmaceuticals
Amneal-pharmaceuticals
Amneal-pharmaceuticals-stock-performance
News-ratings-for-amneal-pharmaceuticals-daily
Raymond-james-associates
York-mellon-corp
Barclays
Principal-financial-group-inc
Nasdaq
Sg-americas-securities

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Reaffirmed by Truist Financial

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Reaffirmed by Truist Financial
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Texas
United-states
Piper-sandler
Amneal-pharmaceuticals-inc
Amneal-pharmaceuticals
Amneal-pharmaceuticals-trading
News-ratings-for-amneal-pharmaceuticals-daily
Vanguard-group-inc
Goldman-sachs-group
Charles-schwab-investment-management-inc
Barclays
Hedge-funds-weigh-in-on-amneal-pharmaceuticals
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.